Vogenx, Inc. SEC filings VOGX

Vogenx, Inc. has 34 filings in SEC EDGAR's recent list, going back to Jan 7, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
8-K Current report
Officer or director change, Regulation FD disclosure
 Oct 9, 2026 Oct 7, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
 Sep 22, 2026 Sep 21, 2026
10-Q Quarterly report Sep 17, 2026 Jun 30, 2026
8-K Current report
Other events
 Aug 19, 2026 Aug 19, 2026
8-K Current report
Bylaw or fiscal year change
 Aug 13, 2026 Aug 13, 2026
S-8 Employee stock plan registration Aug 13, 2026 —
424B4 Prospectus Aug 12, 2026 —
EFFECT Filing Aug 11, 2026 —
CERT Filing Aug 11, 2026 —
8-A12B Form 8-a12b Aug 10, 2026 —
S-1/A Amended registration statement Aug 10, 2026 —
S-1/A Amended registration statement Jul 29, 2026 —
S-1 Registration statement Jul 15, 2026 —
DRS/A Filing Jun 30, 2026 —
DRS/A Filing Apr 2, 2026 —
DRS Filing Feb 20, 2026 —
D Filing Jan 7, 2026 —

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VOGX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Raleigh, NC
SEC filer status
, Emerging growth company
SEC CIK
1903784

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.